Seaweed Iodine Delivered Via Food or Supplementation
INNOVATE
Iodine From Seaweed - a Randomised Controlled Trial of Food Versus Supplementation in Women With Marginal Habitual Iodine Intake
1 other identifier
interventional
96
1 country
1
Brief Summary
In this project, the investigators propose an intervention design testing the efficacy of a food reformulated with seaweed as an ingredient in meal, capsules against placebo and no intervention controls. The randomised control trial (supplementation) will last 24 weeks. The aim is to study the effect of the food matrix on variables associated with iodine nutrition: iodine status and thyroid function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2019
CompletedFirst Submitted
Initial submission to the registry
April 27, 2021
CompletedFirst Posted
Study publicly available on registry
May 6, 2021
CompletedJanuary 9, 2023
January 1, 2023
1.6 years
April 27, 2021
January 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in urinary iodine concentration (UIC)
Change in UIC assessed in pooled spot urine samples at 12 weeks, from baseline
0, 12 weeks
Change in urinary iodine concentration (UIC)
Change in UIC assessed in pooled spot urine samples at 24 weeks, from baseline
0, 24 weeks
Secondary Outcomes (9)
Changes in body weight
0, 12, 24 weeks
Changes in body mass index
0, 12, 24 weeks
Changes in waist circumference
0, 12, 24 weeks
Concentration of thyroid stimulating hormone
0, 12, 24 weeks
Concentration of thyroglobulin
0, 12, 24 weeks
- +4 more secondary outcomes
Other Outcomes (4)
concentration of triglycerides
0, 12, 24 weeks
concentration of total cholesterol
0, 12, 24 weeks
concentration of HDL/LDL cholesterol
0, 12, 24 weeks
- +1 more other outcomes
Study Arms (4)
Reformulated pizza
EXPERIMENTALParticipants must consume a nutritionally balanced pizza reformulated with seaweed (Ascophyllum nodosum) as an ingredient 3 times a week for 24 weeks
Control pizza
PLACEBO COMPARATORParticipants must consume a nutritionally balanced pizza without seaweed, 3 times a week for 24 weeks
Seaweed capsule
EXPERIMENTALParticipants must consume a capsule containing powdered Ascophyllum nodosum 3 times a week for 24 weeks
Control capsule
PLACEBO COMPARATORParticipants must consume an empty capsule 3 times a week for 24 weeks
Interventions
Reformulated food with 400ug of iodine per meal, three times per week (to achieve 122% of weekly recommended intakes - average 140ug/day).
Control (placebo) meal to consume thrice weekly (no iodine supplementation).
Capsules containing seaweed extract, the iodine-rich ingredient in the reformulated pizza, 400ug iodine per capsule, to be consumed three times per week (122% of weekly recommended intake).
Eligibility Criteria
You may qualify if:
- self-reported healthy women
- aged 18 to 60
- pre-menopausal
- with no history of thyroid dysfunction
- without any known allergic reactions to foods
- not on medication that impact on absorption of nutrients from the gut
- not currently taking dietary / multivitamin supplements (must have discontinued usage 2 weeks prior the start of the study)
You may not qualify if:
- pregnancy
- lactation
- habitual consumption of seaweed-based products (\>once per week), milk (\>once per day), sea fish, non-oily, e.g. cod (\>once per week)
- veganism (as food products contains cheese)
- Involvement in another research study where diet is restricted, modified, or dietary habits are studied.
- women who have reached menopause.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Glasgow
Glasgow, G31 2ER, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Emilie Combet
University of Glasgow
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Masking of pizzas was achieved by the use of pizzas with identical appearance and taste. Iodine and control supplements were also identical in appearance. Both pizzas and supplements were provided to investigators already masked. Pizzas labelled X and Y. Supplements labelled A and B
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 27, 2021
First Posted
May 6, 2021
Study Start
February 12, 2018
Primary Completion
September 5, 2019
Study Completion
September 5, 2019
Last Updated
January 9, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share